| First Author | Hakem A | Year | 1999 |
| Journal | J Exp Med | Volume | 189 |
| Issue | 6 | Pages | 957-68 |
| PubMed ID | 10075979 | Mgi Jnum | J:53620 |
| Mgi Id | MGI:1332996 | Doi | 10.1084/jem.189.6.957 |
| Citation | Hakem A, et al. (1999) The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J Exp Med 189(6):957-68 |
| abstractText | Aberrant activation of cell cycle molecules has been postulated to play a role in apoptosis (catastrophic cell cycle). Here we show that in noncycling developing thymocytes, the cyclin- dependent kinase Cdk2 is activated in response to all specific and nonspecific apoptotic stimuli tested, including peptide-specific thymocyte apoptosis. Cdk2 was found to function upstream of the tumor suppressor p53, transactivation of the death promoter Bax, alterations of mitochondrial permeability, Bcl-2, caspase activation, and caspase-dependent proteolytic cleavage of the retinoblastoma protein. Inhibition of Cdk2 completely protected thymocytes from apoptosis, mitochondrial changes, and caspase activation. These data provide the first evidence that Cdk2 activity is crucial for the induction of thymocyte apoptosis. |
